Source: https://www.gpo.gov/fdsys/pkg/USCODE-2010-title21/html/USCODE-2010-title21-chap25.htm
Timestamp: 2016-08-27 03:12:37
Document Index: 777659666

Matched Legal Cases: ['§2001', '§701', '§1001', '§2002', '§702', '§2003', '§703', '§1002', '§1003', '§1004', '§1005']

CHAPTER 25—MISCELLANEOUS ANTI-DRUG ABUSE PROVISIONS
SUBCHAPTER I—ANTI-DOPING AGENCY
2001.Designation of United States Anti-Doping Agency.
2002.Records, audit, and report.
2003.Authorization of appropriations.
SUBCHAPTER II—NATIONAL METHAMPHETAMINE INFORMATION CLEARINGHOUSE
2011.Definitions.
2012.Establishment of clearinghouse and advisory council.
2013.NMIC requirements and review.
2014.Authorization of appropriations.
§2001. Designation of United States Anti-Doping Agency
The term “United States Olympic Committee” means the organization established by the “Ted Stevens Olympic and Amateur Sports Act” (36 U.S.C. 220501 et seq.).
(2) Amateur athletic competition
The term “amateur athletic competition” means a contest, game, meet, match, tournament, regatta, or other event in which amateur athletes compete (36 U.S.C. 220501(b)(2)).
(3) Amateur athlete
The term “amateur athlete” means an athlete who meets the eligibility standards established by the national governing body or paralympic sports organization for the sport in which the athlete competes (36 U.S.C. 22501(b)(1)).1
(4) Gene doping
The term “gene doping” means the nontherapeutic use of cells, genes, genetic elements, or of the modulation of gene expression, having the capacity to enhance athletic performance.
The United States Anti-Doping Agency shall—
(1) serve as the independent anti-doping organization for the amateur athletic competitions recognized by the United States Olympic Committee;
(2) ensure that athletes participating in amateur athletic activities recognized by the United States Olympic Committee are prevented from using performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping;
(3) implement anti-doping education, research, testing, and adjudication programs to prevent United States Amateur Athletes participating in any activity recognized by the United States Olympic Committee from using performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping;
(4) serve as the United States representative responsible for coordination with other anti-doping organizations coordinating amateur athletic competitions recognized by the United States Olympic Committee to ensure the integrity of athletic competition, the health of the athletes and the prevention of use of performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping by United States amateur athletes; and
(5) permanently include “gene doping” among any list of prohibited substances adopted by the Agency.
(Pub. L. 109–469, title VII, §701, Dec. 29, 2006, 120 Stat. 3533.)
Pub. L. 109–469, title X, §1001, Dec. 29, 2006, 120 Stat. 3537, provided that: “This title [enacting subchapter II of this chapter] may be cited as the ‘National Methamphetamine Information Clearinghouse Act of 2006’.”
1 So in original. Probably should be “220501(b)(1)).”
§2002. Records, audit, and report
The United States Anti-Doping Agency shall keep correct and complete records of account.
The United States Anti-Doping Agency shall submit an annual report to Congress which shall include—
(1) an audit conducted and submitted in accordance with section 10101 of title 36; and
(Pub. L. 109–469, title VII, §702, Dec. 29, 2006, 120 Stat. 3534.)
§2003. Authorization of appropriations
There are authorized to be appropriated to the United States Anti-Doping Agency—
(Pub. L. 109–469, title VII, §703, Dec. 29, 2006, 120 Stat. 3534.)
(1) the term “Council” means the National Methamphetamine Advisory Council established under section 2012(b)(1) of this title;
(2) the term “drug endangered children” means children whose physical, mental, or emotional health are at risk because of the production, use, or other effects of methamphetamine production or use by another person;
(3) the term “National Methamphetamine Information Clearinghouse” or “NMIC” means the information clearinghouse established under section 2012(a) of this title; and
(4) the term “qualified entity” means a State, local, or tribal government, school board, or public health, law enforcement, nonprofit, community anti-drug coalition, or other nongovernmental organization providing services related to methamphetamines.
(Pub. L. 109–469, title X, §1002, Dec. 29, 2006, 120 Stat. 3537.)
The Council shall consist of 10 members appointed by the Attorney General—
(Pub. L. 109–469, title X, §1003, Dec. 29, 2006, 120 Stat. 3538.)
The NMIC shall include—
Not later than 30 days after the date of submission of an item by a qualified entity, the Council shall review an item submitted for posting on the website described in subsection (b)(2)—
Not later than 45 days after the date of submission of an item, the Council shall—
(Pub. L. 109–469, title X, §1004, Dec. 29, 2006, 120 Stat. 3538.)
(1) for fiscal year 2007—
(B) such sums as are necessary for the operation of the NMIC and Council; and
(2) for each of fiscal years 2008 and 2009, such sums as are necessary for the operation of the NMIC and Council.
(Pub. L. 109–469, title X, §1005, Dec. 29, 2006, 120 Stat. 3539.)